Evidence map›Paper›PMID 41893198›Full record

ReviewJournal of functional biomaterials2026

Therapeutic Biomaterials for Chronic Osteomyelitis: Time-Space-Control Strategies for Infection Control and Bone Repair-A Narrative Review.

Jinqiu Tian, Qi Meng, Peixun Zhang

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jinqiu TianDepartment of Trauma and Orthopaedics, Peking University People's Hospital, Beijing 100044, China.
Qi MengDepartment of Trauma and Orthopaedics, Peking University People's Hospital, Beijing 100044, China.
Peixun ZhangDepartment of Trauma and Orthopaedics, Peking University People's Hospital, Beijing 100044, China.ORCID 0000-0001-7200-2281

Funding

Beijing National Science Foundation 7254551Beijing Natural Science Foundation Z241100009024027Capital Medical Science and Technology Innovation Achievement Transformation Promotion Plan Empowerment Project YC202401QX0320Fundamental Research Funds for the Central Universities BMU2025YFJHPY022National Key Research and Development Program of China 2024YFC2418803National Natural Science Foundation of China 22278003National Trauma Medicine Center Open Research Project GK2025004Natural Science Foundation of Shandong Province ZR2023QH298Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation BMU2025YFJHPY022Peking University People's Hospital Research and Development Fund RDEB2024-02Peking University People's Hospital Research and Development Fund RDGS2022-01
6 · The paper itself

Abstract

Chronic osteomyelitis and infected bone defects are driven by recurrent infection, biofilm persistence, and dysregulated inflammation, but conventional "eradicate bacteria and fill the defect" approaches often fail to restore a regenerative microenvironment. Herein, we review biofilm-associated immune dysfunction in impaired angiogenesis/osteogenesis and summarize biomaterials that couple infection control with tissue regeneration. We integrate representative platforms into a "Time-Space-Control" framework: (i) time-programmed systems that sequence early antibiofilm/antibacterial actions with later pro-angiogenic and osteogenic cues; (ii) space-focused designs that enhance defect localization, penetration, and coverage of infected niches; and (iii) controllable strategies that enable pathology-responsive and/or externally triggered, on-demand modulation. Based on this synthesis, we propose a practical 4P principle to guide programmable therapeutic biomaterials. Overall, explicitly managing timing, localization, and controllability may improve the alignment of antimicrobial therapy, immune reprogramming, and regenerative support for chronic infected bone repair.

Indexed as

biofilmchronic osteomyelitisdrug deliveryimmunomodulationinfected bone defectprogrammable therapyregenerative biomaterials

Identifiers

PMID41893198
PMCPMC13027529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.